|
2024
|
Invention
|
Method for treating c. acnes bacteria-associated diseases.
The present invention concerns a meth... |
|
|
Invention
|
Detection and treatment of c. acnes bacteria-associated diseases. Cutibacterium acnesC. acnesC. a... |
|
|
Invention
|
Phage-derived particles for in situ delivery of dna payload into c. acnes population.
The invent... |
|
|
Invention
|
Bacterial delivery vehicle, process of production and uses thereof.
The present invention relate... |
|
|
Invention
|
Production of lytic phages.
The present invention concerns a production bacterial cell for produ... |
|
|
Invention
|
Optimized vector for delivery in microbial populations.
The present invention relates to a vecto... |
|
|
Invention
|
Production bacterial cells and use thereof in production methods.
The present invention concerns... |
|
2023
|
Invention
|
Cutibacterium acnes recombinant phages, method of production and uses thereof.
The invention rel... |
|
|
Invention
|
C. acnes population. C. acnes containing these vectors or modified by transduction of these phage... |
|
|
Invention
|
Microbiome modulation of a host by delivery of dna payloads with minimized spread. The present in... |
|
|
Invention
|
Production of lytic phages. The present invention concerns a production bacterial cell for produc... |
|
|
Invention
|
Production bacterial cells and use thereof in production methods. wherein said production bacteri... |
|
|
Invention
|
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure mic... |
|
|
Invention
|
Chimeric receptor binding proteins for use in bacterial delivery vehicles.
The present disclosur... |
|
|
Invention
|
Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins. A method for th... |
|
|
Invention
|
Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy.
The invention relat... |
|
|
Invention
|
Transcriptional control in prokaryotic cells using dna-binding repressors. Methods and compositio... |
|
2022
|
Invention
|
Chimeric receptor binding proteins resistant to proteolytic degradation.
The present disclosure ... |
|
|
Invention
|
Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins. The present ... |
|
|
Invention
|
Engineered bacterial strains comprising a transgene.
The present invention concerns a method to ... |
|
|
Invention
|
Engineered bifidobacterium strains comprising a transgene.
The present invention concerns a meth... |
|
|
Invention
|
Methods involving bacterial strain replacement. The present invention concerns a method for reduc... |
|
|
Invention
|
Methods involving bacteroides strain replacement. BacteroidesBacteroidesBacteroidesBacteroidesBac... |
|
|
Invention
|
C. acnes phages comprising transgenes. C. acnes recombinant phages and methods of using these rec... |
|
|
Invention
|
Bacterial delivery vehicles comprising tracer nucleic acid sequences.
The present disclosure rel... |
|
|
Invention
|
Sequence-specific antimicrobials by blocking dna repair. The invention relates to the improvement... |
|
|
Invention
|
Production of lytic phages. wherein the expression of at least one of said phage structural genes... |
|
|
Invention
|
Production bacterial cells and use thereof in production methods. The present invention concerns ... |
|
|
Invention
|
Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins for treating ... |
|
|
Invention
|
Method for killing bacteria with an engineered postbiotic. The present invention concerns a postb... |
|
|
Invention
|
Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins. The present inv... |
|
2021
|
Invention
|
Chimeric receptor binding proteins resistant to proteolytic degradation. The present disclosure p... |
|
|
Invention
|
Phage-derived particles for in situ delivery of dna payload into c. acnes population. The inventi... |
|
|
Invention
|
Method of containment of nucleic acid vectors introduced in a microbiome population.
The inventi... |
|
|
Invention
|
Specific decolonization of antibiotic resistant bacteria for prophylactic purposes.
The inventio... |
|
2020
|
G/S
|
Non-medicated toiletry preparations and cosmetic preparations; cosmetics; non-medicated skin crea... |
|
2018
|
G/S
|
Cosmetics; Non-medicated toiletry preparations and cosmetic products, namely, non-medicated skin ... |
|
|
G/S
|
Non-medicated toiletry preparations and cosmetic products;
cosmetics; non-medicated skin creams;... |
